Company Overview and News

 
Nasdaq Hosted 2nd Nasdaq International Designation Virtual Investor Conference

2018-04-03 globenewswire
NEW YORK, April 03, 2018 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (Nasdaq:NDAQ) announced the conclusion of its Nasdaq International Designation Virtual Investor Conference on March 21, 2018. In collaboration with BNY Mellon Depositary Receipts, Nasdaq welcomed select BNY Mellon Level I ADR Issuers from Australia and New Zealand to present their current state of business to a broad audience, including potential investors.
Upvote Downvote

 
Starpharma Holdings' cabazitaxel is second DEP product to enter clinical stage

2018-01-31 proactiveinvestors.com.au
Starpharma Holdings Limited’s (ASX:SPL) (OTCQX:SPHRY) approval to commence its phase I/II clinical trial for DEP® cabazitaxel is an important milestone.
Upvote Downvote

 
Starpharma Shares Jumped on Phase III Results of Vivagel

2017-08-07 biospace
Melbourne, Australia; 7 August 2017: Starpharma (ASX: SPL, OTCQX: SPHRY) today announced that its two phase 3 trials of VivaGel® BV for prevention of recurrent bacterial vaginosis (rBV) achieved their primary objective demonstrating statistically significant superiority compared to placebo in preventing rBV based on topline data.
Upvote Downvote

 
News Gets Better, Starpharma Sells Agrochemicals Business: Strategic And Raises $26 Million

2017-06-14 seekingalpha
Starpharma’s Priostar dendrimer technology has been applied to delivery of agricultural products, but it is a distraction to its pharmaceuticals business.
Upvote Downvote

 
Agrium Acquires Starpharma Holdings' Agrochemical Business

2017-06-14 zacks
Agrium Inc.’s (AGU - Free Report) subsidiary, Loveland Products, Inc. has announced the completion of the acquisition of Starpharma Holdings Limited's agrochemical business for $35 million. The acquired business is focused on developing its proprietary Priostar dendrimer polymer technology portfolio. The transaction includes assets such as key intellectual property and a small number of dedicated staff based in Melbourne, Australia which will support Agrium's innovation and technology strategy.
Upvote Downvote

 
Agrium Announces Acquisition of Starpharma's Agrochemical Polymer Technology Business

2017-06-13 marketwired
CALGARY, AB--(Marketwired - June 13, 2017) - Agrium Inc. (TSX: AGU) (NYSE: AGU), through its subsidiary Loveland Products, Inc. announced today that it has closed on the acquisition of Starpharma Holdings Limited's agrochemical business focused on development of its proprietary Priostar® dendrimer polymer technology portfolio for $35 million. The acquisition is comprised of key intellectual property, as well as a small number of dedicated staff based in Melbourne, Australia.
Upvote Downvote

 
Ansell Launches VivaGel Condom In Canada

2017-04-12 devicespace
MELBOURNE, Australia--(BUSINESS WIRE)--Starpharma Holdings Ltd (ASX:SPL, OTCQX:SPHRY) is pleased to announce the VivaGel® condom has been launched in Canada by Ansell (ASX:ANN) under the LifeStyles® Dual Protect™ brand. These condoms carry the VivaGel® brand and Starpharma will receive royalties based on sales.
Upvote Downvote

 
Starpharma's VivaGel BV granted QIDP status by FDA

2017-01-12 seekingalpha
Starpharma Holdings (OTCQX:SPHRY) announces that the FDA has granted Qualified Infectious Disease Product (QIDP) and Fast Track status for VivaGel BV (astodrimer sodium) for the treatment and prevention of bacterial vaginosis (BV).
Upvote Downvote

 
One CEO’s Push to Make Cancer Drugs and Condoms Great Again - Bloomberg

2016-11-16 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Bacterial Vaginosis Pipeline H2 2016 Market Research Report

2016-08-18 prnewswire
RnRMarketResearch.com adds "Bacterial Vaginosis - Pipeline Review, H2 2016" market research report complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Bacterial Vaginosis and special features on late-stage and discontinued projects.
Upvote Downvote

 
David Jones head office to move to Melbourne

2016-08-05 abc.net.au
The Victorian Government says more than 800 jobs will be created with news South Africa's Woolworths Holdings will set up its Australasian office in Melbourne.
Upvote Downvote

 
Starpharma Signs License For A VivaGel Condom In China

2016-07-21 devicespace
MELBOURNE, Australia--(BUSINESS WIRE)--Starpharma Holdings Ltd (ASX:SPL)(OTCQX:SPHRY) today announced the signing of an exclusive license and supply agreement with Shenyang Sky and Land Latex Co. Ltd. (Sky and Land) for the manufacture and sale of VivaGel® condoms to the Government segment of the Chinese condom market. This agreement follows the signing of the MOU with Sky and Land in December 2015.
Upvote Downvote

1
Colon Cancer Pipeline Market 2016 Review Report Covering Therapeutics Development

2016-07-18 prnewswire
ReportsnReports.com adds "Colon Cancer - Pipeline Review, H1 2016" to its store providing an overview of the Colon Cancer's therapeutic pipeline complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Colon Cancer and special features on late-stage and discontinued projects.
Upvote Downvote

 
Australia’s Starpharma develops Zika-proof condoms for athletes ahead of Rio Olympics

2016-05-17 biospectrumasia
It's fast, free and easy to sign in with Facebook, Google, or Yahoo. Be connected on your terms - we won't share anything without your permission
Upvote Downvote

 
Australia's Starpharma, Ansell to supply anti-Zika condoms for Olympics | Reuters

2016-05-16 reuters
SYDNEY Australian pharmaceutical company Starpharma Holdings Ltd said it is teaming up with world No. 2 condom maker Ansell Ltd to supply Zika virus-proof condoms to the Australian Olympic team ahead of the 2016 Rio de Janeiro games.
Upvote Downvote

Related Articles

LPCN: Lipocine Inc Analysis and Research Report

23h - Asif

Overview Lipocine is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. The company's proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Lipocine has a portfolio of proprietary product candidates designed to produce favorable pharmacokinetic (“PK”) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The company's lead product candidate, TLANDO™, is an oral testosterone replacement therapy (“TRT”) and is currently under review by the United States Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (“...

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...